BDXB — Becton Dickinson and Co Share News
0.000.00%
Last trade - 00:00- $71.51bn
- $87.75bn
- $18.87bn
Brief: BD Gains 510(K) Clearance Of Artificial Intelligence Software For MRSA Diagnostics
U.S. RESEARCH ROUNDUP-Iveric Bio, Booking Holdings, Netscout Systems
Becton Dickinson and Co reports results for the quarter ended in March - Earnings Summary
Becton Dickinson raises 2023 profit forecast as demand rebounds
Brief: BD Reports Second Quarter Fiscal 2023 Financial Results
Brief: Becton Dickinson posts Q2 revenue USD 4,821 million
What to Watch in the Day Ahead - Thursday, May 4
Becton Dickinson and Co expected to post earnings of $2.74 a share - Earnings Preview
What to Watch for the Week Ahead and on Monday, May 1
RCS - Baillie Gifford Prz - 1599 wins Baillie Gifford Winner of Winners prize
Brief: Becton Dickinson and Co Board Declares Dividend
Upbeat Abbott, Intuitive Surgical reports send medical device stocks higher
Brief: Michelle Quinn Named General Counsel For BD
Brief: Bd Receives FDA 510(K) Clearance For First-Of-Its-Kind High-Throughput Diagnostic Test For Infectious Vaginitis
Brief: Becton Dickinson's Hpv Assay Receives FDA Approval
Bard convinces U.S. appeals court to revive medical-injection device patents
Brief: BD Receives FDA Emergency Use Authorization For Covid-19, Influenza A/B, Rsv Combination Test
Brief: Becton Dickinson Euro Finance S.À R.L. Files For Offering Of Euro-Denominated Notes Guaranteed By Becton, Dickinson And Company, Size Not Disclosed
Brief: BD Announces High-Throughput Single-Cell Multiomics Platform